SOPHiA GENETICS has demonstrated a proof of concept for real time global variant surveillance of spike protein mutations through the SOPHiA GENETICS' secured peer-network and compared findings to the GISAID timeline. Paragon Genomics SARS-CoV-2 panels powered by SOPHiA DDMTM enables labs to detect current and emerging variants with high accuracy and confidence. In this case study, SOPHiA GENETICS' extensive experience in sequencing analytics generate high-quality viral genome data for better research and surveillance of SARS-CoV-2. 

Research Use Only (RUO), Not for Use in Diagnostic Procedures
The information included has been prepared for and is intended for viewing by a global audience. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult local sales representatives
Slawomir Kubrik
Genomic Research Expert, SOPHiA GENETICS
Registration is full. If you have already registered, please log in or use the link from your registration confirmation email.